Current treatment strategies: Collagen vascular diseases in children

Indian Journal of Dermatology

Volumn 57, Issue 6, 2012, Pages 449-458

  Palit, Aparna ^a   Inamadar, Arun C ^a  

^a BLDE UNIVERSITY   (India)

Author keywords

Children; collagen vascular diseases; lupus erythematosus

Indexed keywords

AMCINONIDE; AZATHIOPRINE; BETAMETHASONE DIPROPIONATE; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; HYDROXYCHLOROQUINE; IMIQUIMOD; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; THALIDOMIDE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILD; CHILDHOOD SCLERODERMA; COLLAGEN VASCULAR DISEASE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISCOID LUPUS ERYTHEMATOSUS; DRUG EFFICACY; DRUG PULSE THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE DERMATOMYOSITIS; LUPUS ERYTHEMATOSUS; MAINTENANCE THERAPY; NEWBORN LUPUS ERYTHEMATOSUS; PHOTOTHERAPY; PLASMAPHERESIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC THERAPY; VASCULAR DISEASE;

EID: 84870192189     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.103064     Document Type: Conference Paper

References (54)

1. Falcini F. Vascular and connective tissue diseases in the paediatric world. Lupus 2004;13:77-84. (Pubitemid 38222350)
2. Lee LA. Cutaneous lupus in infancy and childhood. Lupus 2010;19:1112-7.
3. Cherif F, Mebazaa A, Mokni M, El Euch D, Azaiz MI, Dhahri AB. Childhood discoid lupus erythematosus: A Tunisian retrospective study of 16 cases. Pediatr Dermatol 2003;20:295-8. (Pubitemid 36936221)
4. Sampaio MC, De Oliveira ZN, Machado MC, Dos Reis VM, Vilela MA. Discoid lupus erythematosus in children. a retrospective study of 34 patients. Pediatr Dermatol 2008;25:163-7. (Pubitemid 351579595)
5. Miettunen PM, Bruecks A, Remington T. Dramatic response of scarring scalp discoid lupus erythematosus (DLE) to intravenous methylprednisolone, oral corticosteroids and hydroxychloroquine in a 5-year-old child. Pediatr Dermatol 2009;26:338-41.
6. Abe M, Ishikawa O, Miyachi Y. Linear cutaneous lupus erythematosus following the lines of Blaschko. Br J Dermatol 1998;139:307-10. (Pubitemid 28389409)
7. Moises-Alfaro C, Berron-Perez R, Carrasco-Daza D, Gutierrez-Castrellon P, Ruiz Maldonado R. Discoid lupus erythematosus in children: Clinical, histopathologic, and follow-up features in 27 cases. Pediatr Dermatol 2003;20:103-7. (Pubitemid 36438463)
8. Marks SD, Tullus K. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis. Acta Paediatrica 2010;99:967-74.
9. Silverman E. What's new in the treatment of pediatric SLE. J Rheumatol 1996;23:1657-60. (Pubitemid 26290600)
10. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001;28:2103-8. (Pubitemid 32803791)
11. Falcini F, Capannini S, Martini G, La Torre F, Vitale F, Mangiantini F, et al. Mycophenolate mofetil for the treatment of juvenile onset SLE: A multicenter study. Lupus 2009;18:139-43.
12. Bichile LS, Pruthi MS, Zarkar A, Sabnis SA. Favourable outcome in a patient with central nervous system lupus. J Assoc Physicians India 1999;47:1201-2.
13. Chetan G, Mahadevan S, Sulanthang K, Narayanan P. Intravenous immunoglobulin therapy of lupus pneumonitis. Indian J Pediatr 2007;74:1032-3. (Pubitemid 350243612)
14. Wright EC, Tullus K, Dillon MJ. Retrospective study of plasma exchange in children with systemic lupus erythematosus. Pediatr Nephrol 2004;19:1108-14. (Pubitemid 39317514)
15. Marks SD, Tullus K. Successful outcomes with rituximab therapy in refractory childhood systemic lupus erythematosus. Pediatr Nephrol 2006;21:598-9.
16. Podolskaya A, Stadermann M, Pilkington C, Marks SD, Tullus K. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child 2008;93:401-6. (Pubitemid 352025791)
17. Wulffraat NM, Sanders EA, Kamphuis SS, Rigkers GT, Kuis W, Lilien M, et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001;44:728-31. (Pubitemid 32234633)
18. Wisuthsarewong W, Soongswang J, Chantorn R. Neonatal lupus erythematosus: Clinical character, investigation, and outcome. Pediatr Dermatol 2011;28:115-21.
19. McCauliffe DP. Neonatal lupus erythematosus. In: Harper J, Oranje A, Prose N, editors. Textbook of pediatric Dermatology. 2nd ed. Oxford: Blackwell Publishing Ltd; 2006. P. 126-33.
20. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Lupus erythematosus: Results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-7. (Pubitemid 29247102)
21. Chiu YE, Co DO. Juvenile dermatomyositis: Immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. Pediatr Dermatol 2011;28:357-67.
22. Halbert AR. Juvenile dermatomyositis. Australas J Dermatol 1996;37:106-8. (Pubitemid 126442364)
23. Reed AM, Lopez M. Juvenile dermatomyositis. Recognition and treatment. Pediatr Drugs 2002;4:315-21.
24. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindaq A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47:505-11.
25. Huber AM. Juvenile dermatomyositis. Advances in pathogenesis, evaluation, and treatment. Pediatr Drugs 2009;11:361-74.
26. Riley P, Maillard SM, Wedderburn LR, Woo P, Murray KJ, Pilkington CA. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis: A review of efficacy and safety. Rheumatology (Oxford) 2004;43:491-6. (Pubitemid 38495769)
27. Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 2008;47:877-80. (Pubitemid 351796377)
28. Levine TD. Rituximab in the treatment of dermatomyositis: An open. label pilot study. Arthritis Rheum 2005;52:601-7. (Pubitemid 40216325)
29. Holzer U, Van Royen. Kerkhof A, Van Der Torre P, Kuemmerle. Deschner J, Well C, Handgretinger R, et al. Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scand J Rheumatol 2010;39:88-92.
30. Wu JJ, Metz BJ. Calcinosis cutis of juvenile dermatomyositis treated with incision and drainage. Dermatol Surg 2008;35:575-7. (Pubitemid 351442707)
31. Sampaio C, Visentin MT, Howel K, Woo P, Harper J. Morphoea (Synonym: Localized Scleroderma). In: Harper J, Oranje A, Prose N, editors. Textbook of Pediatric Dermatology. 2nd ed. Oxford: Blackwell Publishing Ltd; 2006. P. 2020-9.
32. Mancuso G, Berdondini RM. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003;13; 290-2.
33. Mancuso G, Berdondini RM. Localized scleroderma: Response to occlusive treatment with tacrolimus ointment. Br J Dermatol 2005;152:180-2.
34. Dytoc MT, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod for morphea. Br J Dermatol 2005;153:815-20. (Pubitemid 41415912)
35. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998;39:211-5. (Pubitemid 28367331)
36. Dytoc MT, Kossintseva I, Ting PT. First case series on the use of calcipotriol betamethasone dipropionate for morphea. Br J Dermatol 2007;157:615-8. (Pubitemid 47256106)
37. Kerscher M, Meurer M, Sander C, Volkenandt M, Lehmann P, Plewig G, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996;132:1280-2. (Pubitemid 26386612)
38. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1 and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006;54:440-7. (Pubitemid 43243447)
39. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-44. (Pubitemid 27265906)
40. Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: A retrospective and prospective study. Br J Dermatol 2010;162:445-7.
41. Sator PG, Radakovic S, Schulmeister K, Honigsmann H, Tanew A. Medium dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20. MHz ultrasound assessment. J Am Acad Dermatol 2009;60:786-91.
42. Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 2001;18:241-5. (Pubitemid 32567879)
43. Neustadter JH, Samarin F, Carlson KR, Giradi M. Extracorporeal photochemotherapy for generalized deep morphea. Arch Dermatol 2009;145:127-30.
44. Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children. Br J Dermatol 2006;155:1013-20. (Pubitemid 44564513)
45. Martini G, Ramanan AV, Falcini F, Girschik H, Goldsmith DP, Zulian F. Successful treatment of severe or methotrexate resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford) 2009;48:1410-3.
46. Humbert P, Aubin F, Dupond JL, Delaporte E. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma. Arch Dermatol 1995;131:850-1.
47. Strauss RM, Bhushan M, Goodfield MJ. Good response of linear scleroderma in a child to ciclosporin. Br J Dermatol 2004;150:790-2. (Pubitemid 38586248)
48. Crespo MP, Betlloch IM, Mataix JD, Costa AL, Nortes IB. Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl. Pediatr Dermatol 2009;26:118-20.
49. Diab M, Coloe JR, Magro C, Bechtel MA. Treatment of recalcitrant generalized morphea with infliximab. Arch Dermatol 2010;146:601-4.
50. Fett NM. Morphea: Evidence based recommendations for treatment. Indian J Dermatol Venereol Leprol 2012;78:135-41.
51. Denton CP, Black CM. Systemic sclerosis in childhood. In: Harper J, Oranje A, Prose N, editors. Textbook of pediatric Dermatology. 2nd ed. Oxford: Blackwell Publishing Ltd; 2006. p. 2030-40.
52. Panda S. Scleroderma in children: Emerging management issues. Indian J Dermatol Venereol Leprol 2010;76:348-56.
53. Zulian F. Systemic sclerosis and localized scleroderma in childhood. Rheum Dis Clin North Am 2008;34:239-55. (Pubitemid 351329457)
54. Zulian F, Corona F, Gerloni V, Falcini F, Buoncompagni A, Scarazatti M, et al. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Rheumatology (Oxford) 2004;43:229-33. (Pubitemid 38219681)